Come up with a name for your new list and we'll add to it:
Tolera Therapeutics raised a round of funding on May 11, 2009. Investors include
Qualifying Therapeutic Discovery Project.
Tolera Therapeutics is developing targeted therapies for immune suppression and immune tolerance, designed for use in organ transplant surgeries and other medical settings requiring safer, more target…